CMS (867.HK) Joins Hand with Incyte on Ruxolitinib Cream, Brings 1st Repigmentation Drug for Vitiligo Patient

SHENZHEN, CHINA, December 07, 2022 – (SEAPRWire) – China Medical System Holdings Limited (CMS, 867.HK) acquired another blockbuster innovative product in dermatology filed. On December 2, CMS announced that it had, through one of its subsidiaries, a dermatology medical aesthetic company (“CMS Aesthetics”), reached a collaboration agreement with Incyte, a global biopharmaceutical company, obtaining the […]

China Medical System (867.HK) S&P Global CSA Score Achieved Significant Improvement, Leading the Industry Globally

Shenzhen, China, November 18, 2022 – (SEAPRWire) – Recently, the S&P Global Corporate Sustainability Assessment (S&P Global CSA) released the 2022 Environmental, Social and Governance (ESG) scores for China Medical System Holdings Limited (“CMS” or the “Group”). CMS achieved a significant improvement with a score of 53 in 2022 from 36 in 2021, surpassing 92% […]

2022 Seongnam Global Healthcare Convention will be held from Oct. 27,2022 to Oct. 29, 2022

Making a leap forward as the Fourth Industrial Innovation City SEONGNAM, KOREA, October 20, 2022 – (SEAPRWire) – Seongnam City will host the ‘2022 Seongnam Global Healthcare Convention’ at the City Hall from October 27 to 29. Seongnam Global Healthcare Convention (formerly Seongnam International Medical Tourism Convention), which marks its fifth anniversary, will be organized […]

Universal Medical (2666.HK) Announces 2022 Interim Results

– Pursuing Progress in Revenue, Increased by 14.1% – Ensuring Stability and Accommodating the Needs for Pandemic Control HONG KONG, September 01, 2022 – (SEAPRWire) – The board of directors of Genertec Universal Medical Group Co Ltd (the “Company” or “Universal Medical”; Stock code: 2666.HK) is pleased to announce the interim results of the Company […]

CMS Releases Its 2022 Interim Report, Achieves Sustained Growth with Its Platform Strategy

SHENZHEN, CHINA, August 26, 2022 – (SEAPRWire) – China Medical System Holdings Limited (“CMS”, 867.HK) released its 2022 interim report on August 22. In the first half of 2022, CMS delivered an outstanding interim results —— it achieved stable performance growth in several business segments, and solid progress in clinical development and registration of innovative […]